Article
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 May 2009
Pensabene M, Spagnoletti I, Capuano I, Condello C, Pepe S, Contegiacomo A, Lombardi G, Bevilacqua G, Caligo M A
Abstract excerpt
BACKGROUND: Although most BRCA sequence variants are clearly deleterious and unequivocally pathogenetic, several are still classified as variants of unknown significance. PATIENTS AND METHODS: We followed families undergoing oncogenetic counseling from risk identification to risk definition by genetic testing and risk management. RESULTS: We identified two germline mutations in the BRCA2 gene in a woman with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
